Beam Therapeutics
BEAM
BEAM
220 hedge funds and large institutions have $2.32B invested in Beam Therapeutics in 2024 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 80 increasing their positions, 46 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
17% more capital invested
Capital invested by funds: $1.99B → $2.32B (+$333M)
3.57% less ownership
Funds ownership: 89.71% → 86.14% (-3.6%)
53% less call options, than puts
Call options by funds: $13.8M | Put options by funds: $29.1M
Holders
220
Holding in Top 10
3
Calls
$13.8M
Puts
$29.1M
Top Buyers
| 1 | +$70M | |
| 2 | +$39.9M | |
| 3 | +$16.5M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$14.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.7M |
Top Sellers
| 1 | -$140M | |
| 2 | -$42.5M | |
| 3 | -$41.7M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$40M |
| 5 |
State Street
Boston,
Massachusetts
|
-$29.2M |